Pingora Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Hold
1,600
1.12% 23
2026
Q1
$1.47M Sell
1,600
-100
-6% -$101K 0.87% 28
2025
Q4
$1.83M Hold
1,700
1.12% 18
2025
Q3
$1.3M Buy
1,700
+100
+6% +$74.4K 0.86% 26
2025
Q2
$1.25M Sell
1,600
-300
-16% -$233K 0.93% 26
2025
Q1
$1.57M Hold
1,900
1.16% 19
2024
Q4
$1.47M Hold
1,900
0.96% 21
2024
Q3
$1.68M Hold
1,900
1.19% 16
2024
Q2
$1.72M Hold
1,900
1.22% 14
2024
Q1
$1.48M Hold
1,900
1.08% 20
2023
Q4
$1.11M Buy
+1,900
New +$1.11M 0.98% 24

Other funds holding LLY

Pingora Partners's LLY Position: Q2 2026 in Review

Pingora Partners held its Eli Lilly (LLY) position steady in Q2 2026 at 1,600 shares worth $1.92M. The position accounts for 1.12% of the portfolio, ranked #23.

Pingora Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pingora Partners held 1,600 shares of Eli Lilly worth $1.92M as of Q2 2026.
  • Pingora Partners left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.12% of Pingora Partners's portfolio in Q2 2026, its #23 holding.
  • Pingora Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.